FDA: Rated Risk, Two Brands of Eye Drops Withdrawn in US
Washington, DC —
U.S. health officials Tuesday warned consumers about two more eye drops being recalled because of the risk of contamination that can cause vision problems and serious injury.
The announcement follows a recall of eye drops made in India last month, which have been linked to an outbreak of drug-resistant infections. One person died and at least five others suffered permanent vision loss.
There is no indication of a recent recall regarding this product.
The US Food and Drug Administration (FDA) posted separate recall notices for certain eye drops distributed by Pharmedica and Apotex after the companies said they had withdrawn some of their products from the market voluntarily.
Pharmedica last Friday (3/3) said it was pulling two lots of “Purely Soothing 15% MSM Drops” because of “a problem that can lead to blindness.” Over-the-counter eye drops are designed to treat eye irritation. The Phoenix-based company said consumers should immediately stop using the eye drops and return them to where they bought them.
According to the company nearly 2,900 bottles of the eye drops have been recalled. Eye drops are manufactured in Arizona.
The FDA last week posted a separate recall announcement for eye drops made by Apotex, which is recalling six prescription eye drops used to treat a form of glaucoma.
Apotex said it had initiated a recall of the drugs after discovering cracks in some of the caps. Eye drops made by Apotex are distributed as Brimonidine Tartrate Ophthalmic Solution 0.15% and are sold between April-February 2022.
Both companies said the recall of the eye drops was made after consultation with the FDA. [em/jm]